Live news related to ABIONYX PHARMA stock (FR0012616852): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
ABIONYX Pharma announces the development of a new manufacturing process for synthetic sphingomyelin, a key component of its CER-001 product for sepsis…
ABIONYX Pharma announces its annual results for 2025 and outlines its strategic directions focused on actively preparing for the next clinical phase i…
